?

Barton Jacqueline K

Director
Gilead Sciences, Inc.
US, Foster City [HQ]
CIK 1183680

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
24,540
Price per Share :
$91.84
Equivalence :
$2,253,753.60

Transaction History

  • A
    Form 4
    24,540 Shares After Transaction
    Value : $n/a
    $0.0
    05/08/24
  • Footnotes:
    #1 Represents 2,310 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 8, 2024.